New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today, says a researcher at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center in the March 21 issue of the Lancet.
Full article >>
Friday, March 20, 2009
Monoclonal antibodies primed to become potent immune weapons against cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment